“Transferon Oral” improves resolution of infectious diseases by increasing the number of systemic IFN-γ cells in ocular fungal keratitis and enhances the survival of pediatric patients with sepsis by lowering C reactive protein (CRP), rising increases total lymphocyte numbers and decreasing total neutrophil count (Santacruz-Valdes et al., 2010; Castrejon Vazquez et al., 2019). The gene discussed is CRP; the disease is infectious disease.